can you take retatrutide and bpc 157 together for weight loss: Study shows 30% body weight loss Peptide Update - Q&A: Microdosing

Physical activity, particularly resistance training, similarly helps preserve muscle during weight loss

Quality varies

Who should avoid taking GLP-1 medications

All prescribed GLP-1 agonists require close monitoring by physicians in order to recognize and deal with adverse effects

small absolute numbers) Palpitations: up to 3.2% (12 mg) Sinus tachycardia: up to 3.2% (12 mg) QT prolongation on ECG: 1.6% (12 mg) Retatrutide's Heart Rate Effects and Arrhythmia Risk in Obesity Trials Retatrutide and Cardiac Rhythm Safety Dose-Dependent Heart Rate Increase With Low Incidence of Clinically Significant Arrhythmias in Phase 2 Obesity Trials Background Retatrutide (LY3437943) is a novel triple agonist targeting GIP, GLP-1, and glucagon receptors, developed for the treatment of obesity and cardiometabolic disease

Kalita, B., Mackessy, S